Clinical Trial Update: Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for brexpiprazole as adjunctive therapy in adults with major depressive disorder has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2024-02-02